Moderna Inc (MRNA)
Moderna - EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Modernas COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1
Moderna - EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Modernas COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1
There are no comments here yet...